Atlas Trials

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

Clinical trial NCT02832544 · COMPLETED

Trial details

NCT number
NCT02832544
Sponsor
Population Health Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatic Heart Disease
Start date
2016-08-22
Primary completion
2022-08-18
Enrollment
4565

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.